Business Description
Akebia Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US00972D1054
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.8 | |||||
Equity-to-Asset | -0.15 | |||||
Debt-to-Equity | -1.47 | |||||
Debt-to-EBITDA | 10.7 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -9.36 | |||||
Beneish M-Score | -2.15 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -21.3 | |||||
3-Year EBITDA Growth Rate | 73.9 | |||||
3-Year EPS without NRI Growth Rate | 53.7 | |||||
3-Year FCF Growth Rate | 46.1 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.55 | |||||
9-Day RSI | 53.13 | |||||
14-Day RSI | 53.74 | |||||
6-1 Month Momentum % | -12.77 | |||||
12-1 Month Momentum % | -5.29 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.04 | |||||
Quick Ratio | 0.82 | |||||
Cash Ratio | 0.37 | |||||
Days Inventory | 116.71 | |||||
Days Sales Outstanding | 57.66 | |||||
Days Payable | 64.19 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.5 | |||||
Shareholder Yield % | 3.46 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 62.56 | |||||
Operating Margin % | -20.11 | |||||
Net Margin % | -23.18 | |||||
FCF Margin % | -22.33 | |||||
ROA % | -17.19 | |||||
ROIC % | -19.37 | |||||
3-Year ROIIC % | -229.54 | |||||
ROC (Joel Greenblatt) % | -180.69 | |||||
ROCE % | -22.56 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.63 | |||||
EV-to-EBIT | -9.49 | |||||
EV-to-EBITDA | 67.58 | |||||
EV-to-Revenue | 1.79 | |||||
EV-to-Forward-Revenue | 2.42 | |||||
EV-to-FCF | -8.03 | |||||
Earnings Yield (Greenblatt) % | -10.54 | |||||
FCF Yield % | -12.87 |